Japan, July 20 -- TAKEDA PHARMACEUTICAL CO LTD has got intellectual property rights for 'PLASMA KALLIKREIN INHIBITORS AND THEIR USE FOR TREATING HEREDITARY ANGIOEDEMA ATTACKS.' Other related details are as follows:
Application Number: JP,2024-094996
Category (FI): A61K47/26,C07K16/40,A61K39/395@P,A61K47/12,A61K47/02,A61K47/18,A61K9/08,A61P9/00,A61K39/395@N
Stage: Grant (IP right granted following substantive examination.)
Filing Date: June 12, 2024
Publication Date: Aug. 21, 2024
The original document can be viewed at: https://www.j-platpat.inpit.go.jp/p0100
Disclaimer: Curated by HT Syndication.
